WebJul 19, 2024 · 快速开通微博你可以查看更多内容,还可以评论、转发微博。 WebMoreover, Crews et al. [Citation 41] showed that A1874, an MDM2-recruiting, BRD4 degrading PROTAC, which consists of idasanutlin (6) as MDM2 ligand and JQ1 as BRD4/BET inhibitor, was able to degrade the target protein by 98% with nanomolar potency. It is noteworthy that this is the first report of synergistic antiproliferative effect deriving ...
Optimization of PROTAC Ternary Complex Using DNA Encoded …
WebBRD4 PROTACs Are Apoptotic in Primary AML Cells § RNAi screen identifies BRD4 as a therapeutic target in AML Nature478, 524–528 – JQ1 has broad activity in diverse AML subtypes, partially due to effect on MYC – Collaboration with MD Anderson Cancer Center, Dr. Borthakur DMSO 6.2 12.5 25 50 100 200 0 20 40 60 80 100 nM yS003490 S003487 WebPROTAC 4 was the most potent BRD4 degrader reported to date, potently degrading BRD4 at picomolar concentrations. Moreover, PROTAC 4 significantly inhibited the growth of MV-4–11, MOLM-13, and RS4;11 cell growth with IC 50 … gavin ewanyshyn
BRD4 PROTAC as a novel therapeutic approach for the …
WebJan 14, 2024 · The protein levels of BRD2, BRD3, and BRD4 were examined by western blot analysis. Actin was used as a loading control. (C) BEL-7402, SK-HEP-1, SMMC-7721, HuH-7, and MHCC97H cell lines were treated by BETd-260 at 100 nmol/L for 24 h. The protein levels of BRD2, BRD3 and BRD4 were examined by western blot analysis. WebAug 22, 2024 · Recent evidence has indicated that overexpression of the epigenetic reader bromodomain-containing protein 4 (BRD4) contributes to a poor prognosis of lung cancers, and the suppression of its expression promotes cell apoptosis and leads to tumor shrinkage. Proteolysis targeting chimera (PROTAC) has r … WebMay 21, 2015 · BRD4 is a transcriptional coactivator that binds to enhancer and promoter regions by recognition of acetylated lysines on histone proteins and TFs . Recently, we … gavin estes sugar creek